Larvol Delta - A-Longterm-Extension-Study-to-Evaluate-Safety-Tolerability-and-Efficacy-of-AL002-in-Alzheimer39s-Disease

AL002 - Alector, AbbVie

http://clinicaltrials.gov/ct2/show/NCT05744401

Sep 26, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next